Jodie Ingles
#168,346
Most Influential Person Now
Australian cardiac researcher and academic
Jodie Ingles's AcademicInfluence.com Rankings
Jodie Inglesmedical Degrees
Medical
#3606
World Rank
#4089
Historical Rank
Cardiology
#381
World Rank
#393
Historical Rank
Download Badge
Medical
Jodie Ingles's Degrees
- Masters Cardiology University of Melbourne
- PhD Cardiovascular Research Monash University
Why Is Jodie Ingles Influential?
(Suggest an Edit or Addition)According to Wikipedia, Jodie Ingles is an Australian cardiac researcher and professor. They head the Clinical Cardiac Genetics Group in the Molecular Cardiology Program at the Centenary Institute of Cancer Medicine and Cell Biology in Sydney, Australia.
Jodie Ingles's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- New perspectives on the prevalence of hypertrophic cardiomyopathy. (2015) (775)
- A Prospective Study of Sudden Cardiac Death among Children and Young Adults. (2016) (542)
- Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling (2005) (424)
- 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy. (2019) (393)
- Adaptation and validation of the ACMG/AMP variant classification framework for MYH7-associated inherited cardiomyopathies: recommendations by ClinGen’s Inherited Cardiomyopathy Expert Panel (2018) (233)
- Sudden cardiac death in the young: the molecular autopsy and a practical approach to surviving relatives. (2015) (207)
- Evaluating the Clinical Validity of Hypertrophic Cardiomyopathy Genes (2019) (194)
- Mutations in alpha-actinin-2 cause hypertrophic cardiomyopathy: a genome-wide analysis. (2009) (173)
- Whole Genome Sequencing Improves Outcomes of Genetic Testing in Patients With Hypertrophic Cardiomyopathy. (2018) (118)
- 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy: Executive summary. (2019) (113)
- A cost-effectiveness model of genetic testing for the evaluation of families with hypertrophic cardiomyopathy (2011) (111)
- Clinical predictors of genetic testing outcomes in hypertrophic cardiomyopathy (2013) (103)
- The emerging role of the cardiac genetic counselor. (2011) (101)
- Evidence-Based Assessment of Genes in Dilated Cardiomyopathy (2020) (101)
- 2020 APHRS/HRS expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest, and of their families (2020) (94)
- Sudden cardiac death in the young: a clinical genetic approach (2007) (91)
- Psychosocial impact of specialized cardiac genetic clinics for hypertrophic cardiomyopathy (2008) (91)
- Genetic screening of calcium regulation genes in familial hypertrophic cardiomyopathy. (2007) (82)
- Long-term follow-up of implantable cardioverter defibrillator therapy for hypertrophic cardiomyopathy. (2004) (81)
- Determining pathogenicity of genetic variants in hypertrophic cardiomyopathy: importance of periodic reassessment (2013) (79)
- Nonfamilial Hypertrophic Cardiomyopathy: Prevalence, Natural History, and Clinical Implications. (2017) (77)
- Regional Variation in RBM20 Causes a Highly Penetrant Arrhythmogenic Cardiomyopathy (2018) (77)
- A Validated Model for Sudden Cardiac Death Risk Prediction in Pediatric Hypertrophic Cardiomyopathy (2020) (74)
- Implantable cardioverter-defibrillators in previously undiagnosed patients with catecholaminergic polymorphic ventricular tachycardia resuscitated from sudden cardiac arrest. (2019) (73)
- Hypertrophic Cardiomyopathy With Left Ventricular Systolic Dysfunction (2020) (69)
- Multiple Gene Variants in Hypertrophic Cardiomyopathy in the Era of Next-Generation Sequencing (2017) (67)
- Psychological wellbeing and posttraumatic stress associated with implantable cardioverter defibrillator therapy in young adults with genetic heart disease. (2013) (66)
- Role of Genetic Testing in Inherited Cardiovascular Disease: A Review (2017) (64)
- Natural history of genotype positive-phenotype negative patients with hypertrophic cardiomyopathy. (2011) (62)
- Guidelines for genetic testing of inherited cardiac disorders. (2011) (58)
- A novel heterozygous mutation in cardiac calsequestrin causes autosomal dominant catecholaminergic polymorphic ventricular tachycardia. (2016) (55)
- Sex hormone receptor gene variation associated with phenotype in male hypertrophic cardiomyopathy patients. (2008) (55)
- Application of Genetic Testing in Hypertrophic Cardiomyopathy for Preclinical Disease Detection (2015) (55)
- Conveying a probabilistic genetic test result to families with an inherited heart disease. (2014) (55)
- Posttraumatic Stress and Prolonged Grief After the Sudden Cardiac Death of a Young Relative. (2016) (54)
- Molecular autopsy in victims of inherited arrhythmias (2015) (52)
- Postmortem molecular analysis of KCNQ1 and SCN5A genes in sudden unexplained death in young Australians. (2008) (51)
- Interdisciplinary psychosocial care for families with inherited cardiovascular diseases. (2016) (47)
- Cardiac troponin I mutations in Australian families with hypertrophic cardiomyopathy: clinical, genetic and functional consequences. (2005) (46)
- The value of cardiac genetic testing. (2014) (43)
- Prolongation of the QTc interval predicts appropriate implantable cardioverter-defibrillator therapies in hypertrophic cardiomyopathy. (2013) (43)
- Association of Race With Disease Expression and Clinical Outcomes Among Patients With Hypertrophic Cardiomyopathy. (2019) (42)
- Progression of left ventricular hypertrophy and the angiotensin-converting enzyme gene polymorphism in hypertrophic cardiomyopathy. (2004) (40)
- Long-term follow-up of patients with obstructive hypertrophic cardiomyopathy treated with dual-chamber pacing. (2005) (40)
- Integrated Guidance for Enhancing the Care of Familial Hypercholesterolaemia in Australia. (2020) (40)
- Physical activity in hypertrophic cardiomyopathy: prevalence of inactivity and perceived barriers (2016) (39)
- Factors influencing uptake of familial long QT syndrome genetic testing (2016) (38)
- Poor psychological wellbeing particularly in mothers following sudden cardiac death in the young (2013) (37)
- Tweeting our way to cardiovascular health. (2013) (34)
- Nonfamilial Hypertrophic CardiomyopathyCLINICAL PERSPECTIVE (2017) (34)
- Health status of cardiac genetic disease patients and their at-risk relatives. (2013) (34)
- Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathy (2021) (33)
- Genetic Testing in Inherited Heart Diseases. (2016) (33)
- Cardiovascular Effects of Energy Drinks in Familial Long QT Syndrome: A Randomized Cross-Over Study. (2017) (32)
- Whole-Genome Sequencing as a First-Line Genetic Test in Familial Dilated Cardiomyopathy (2018) (32)
- Concealed Arrhythmogenic Right Ventricular Cardiomyopathy in Sudden Unexplained Cardiac Death Events. (2018) (29)
- Perceptions of genetic variant reclassification in patients with inherited cardiac disease (2019) (28)
- Communication of genetic information to families with inherited rhythm disorders. (2017) (28)
- Attitudes, knowledge and consequences of uncertain genetic findings in hypertrophic cardiomyopathy (2017) (27)
- Exome sequencing–based molecular autopsy of formalin-fixed paraffin-embedded tissue after sudden death (2017) (27)
- Genetic testing for inherited heart diseases: longitudinal impact on health-related quality of life (2012) (27)
- Relations between right ventricular morphology and clinical, electrical and genetic parameters in Brugada Syndrome (2018) (26)
- An International Multicenter Evaluation of Inheritance Patterns, Arrhythmic Risks, and Underlying Mechanisms of CASQ2-Catecholaminergic Polymorphic Ventricular Tachycardia (2020) (25)
- Worldwide differences in primary prevention implantable cardioverter defibrillator utilization and outcomes in hypertrophic cardiomyopathy. (2021) (25)
- Spatial and Functional Distribution of MYBPC3 Pathogenic Variants and Clinical Outcomes in Patients With Hypertrophic Cardiomyopathy (2020) (24)
- Recommendations for clinical interpretation of variants found in non-coding regions of the genome (2021) (23)
- Temporal Trends in Sudden Cardiac Death From 1997 to 2010: A Data Linkage Study. (2017) (22)
- The Australian Genetic Heart Disease Registry. (2013) (22)
- Key Value of RNA Analysis of MYBPC3 Splice-Site Variants in Hypertrophic Cardiomyopathy (2019) (22)
- Associations Between Female Sex, Sarcomere Variants and Clinical Outcomes in Hypertrophic Cardiomyopathy. (2020) (20)
- Burden of Recurrent and Ancestral Mutations in Families With Hypertrophic Cardiomyopathy (2017) (19)
- Delay to diagnosis amongst patients with catecholaminergic polymorphic ventricular tachycardia. (2014) (18)
- Social determinants of health in the setting of hypertrophic cardiomyopathy. (2015) (17)
- Genetic Testing for Cardiomyopathies in Clinical Practice. (2018) (17)
- Disease-specific variant pathogenicity prediction significantly improves variant interpretation in inherited cardiac conditions (2020) (17)
- Psychological Wellbeing and Posttraumatic Stress Associated with Implantable Cardioverter Defibrillator Therapy in Young Adults with Genetic Heart Disease (2013) (17)
- Minding the Genes: a Multidisciplinary Approach towards Genetic Assessment of Cardiovascular Disease (2017) (17)
- Challenges of Exercise Recommendations and Sports Participation in Genetic Heart Disease Patients (2015) (17)
- Molecular diagnostics of cardiomyopathies: the future is here. (2011) (16)
- Psychosocial Implications of Living with Catecholaminergic Polymorphic Ventricular Tachycardia in Adulthood (2018) (16)
- Establishment of an Australian National Genetic Heart Disease Registry. (2008) (16)
- Lack of genotype-phenotype correlation in Brugada Syndrome and Sudden Arrhythmic Death Syndrome families with reported pathogenic SCN1B variants. (2018) (15)
- A balanced translocation disrupting SCN5A in a family with Brugada syndrome and sudden cardiac death. (2019) (15)
- Implantable cardioverter–defibrillator therapy in Australia, 2002–2015 (2018) (14)
- Rarity and phenotypic heterogeneity provide challenges in the diagnosis of Andersen-Tawil syndrome: Two cases presenting with ECGs mimicking catecholaminergic polymorphic ventricular tachycardia (CPVT). (2015) (13)
- Clinical and genetic features of Australian families with long QT syndrome: A registry-based study (2016) (13)
- Psychosocial care and cardiac genetic counseling following sudden cardiac death in the young (2017) (13)
- Discordant clinical features of identical hypertrophic cardiomyopathy twins (2021) (12)
- Genetic architecture of left ventricular noncompaction in adults (2020) (12)
- External validation of the HCM Risk-Kids model for predicting sudden cardiac death in childhood hypertrophic cardiomyopathy (2021) (12)
- The End Unexplained Cardiac Death (EndUCD) Registry for Young Australian Sudden Cardiac Arrest. (2020) (11)
- Homozygous mutation in the cardiac troponin I gene: clinical heterogeneity in hypertrophic cardiomyopathy. (2013) (11)
- Genome sequencing as a first-line genetic test in familial dilated cardiomyopathy (2018) (11)
- Precision Medicine in Cardiovascular Disease: Genetics and Impact on Phenotypes: JACC Focus Seminar 1/5. (2021) (11)
- Psychological Issues in Managing Families with Inherited Cardiovascular Diseases. (2019) (10)
- Sex Disparities in Sudden Cardiac Death (2021) (10)
- Rare desmin variant causing penetrant life-threatening arrhythmic cardiomyopathy (2018) (10)
- Determining pathogenicity in cardiac genetic testing: Filling in the blank spaces. (2015) (9)
- Epidemiology and clinical characteristics of atrial fibrillation in patients with inherited heart diseases (2020) (9)
- Genetic architecture of left ventricular noncompaction in adults. (2020) (9)
- Health Status of Cardiac Genetic Disease Patients and Their At-risk Relatives (2011) (9)
- Needs analysis of parents following sudden cardiac death in the young (2020) (9)
- Genetic variants associated with inherited cardiovascular disorders among 13,131 asymptomatic older adults of European descent (2021) (9)
- Psychosocial Impact of a Positive Gene Result for Asymptomatic Relatives at Risk of Hypertrophic Cardiomyopathy (2018) (9)
- A Control Theory-Based Pilot Intervention toIncrease Physical Activity in Patients WithHypertrophic Cardiomyopathy. (2018) (8)
- Characterization of clinically relevant copy-number variants from exomes of patients with inherited heart disease and unexplained sudden cardiac death (2020) (8)
- Time to Rethink the Genetic Architecture of Long QT Syndrome (2020) (8)
- Revisiting Genome Sequencing Data in Light of Novel Disease Gene Associations. (2019) (8)
- Transcriptome Sequencing of Patients With Hypertrophic Cardiomyopathy Reveals Novel Splice-Altering Variants in MYBPC3 (2021) (8)
- Development of a communication aid for explaining hypertrophic cardiomyopathy genetic test results (2017) (8)
- Impact of the implantable cardioverter defibrillator on confidence to undertake physical activity in inherited heart disease: A cross-sectional study (2017) (8)
- Exome sequencing identifies a novel mutation in the MYH6 gene in a family with early-onset sinus node dysfunction, ventricular arrhythmias, and cardiac arrest☆ (2015) (7)
- 2020 APHRS/HRS expert consensus statement on the investigation of decedents with sudden unexplained death and patients with sudden cardiac arrest, and of their families (2020) (7)
- Hypertrophic Cardiomyopathy: Genetic Testing and Risk Stratification (2021) (7)
- Pathogenicity of Hypertrophic Cardiomyopathy Variants: A Path Forward Together. (2017) (7)
- Sex Differences in Hypertrophic Cardiomyopathy: Interaction With Genetics and Environment (2021) (7)
- Sudden deaths during the largest community running event in Australia: A 25-year review. (2016) (6)
- Patients With Genetic Heart Disease and COVID-19: A Cardiac Society of Australia and New Zealand (CSANZ) Consensus Statement (2020) (6)
- Computational prediction of protein subdomain stability in MYBPC3 enables clinical risk stratification in hypertrophic cardiomyopathy and enhances variant interpretation (2020) (6)
- NON-FAMILIAL HYPERTROPHIC CARDIOMYOPATHY: PREVALENCE, NATURAL HISTORY AND CLINICAL IMPLICATIONS (2017) (6)
- Global approaches to cardiogenetic evaluation after sudden cardiac death in the young: A survey among healthcare professionals. (2021) (6)
- LAMP2 shines a light on cardiomyopathy in an athlete (2017) (6)
- Psychological adaptation to molecular autopsy findings following sudden cardiac death in the young (2018) (6)
- Preventing sudden cardiac death in athletes (2016) (6)
- Sudden cardiac death rates in an Australian population: a data linkage study. (2015) (6)
- The genetic architecture of Plakophilin 2 cardiomyopathy (2021) (6)
- Expanding the genetic spectrum of hypertrophic cardiomyopathy: X marks the spot. (2013) (5)
- Arrhythmia in Cardiomyopathy: Sex and Gender Differences (2021) (5)
- NOS1AP Polymorphisms Modify QTc Interval Duration But Not Cardiac Arrest Risk in Hypertrophic Cardiomyopathy (2015) (5)
- A clinical approach to genetic testing for non-specialists (2017) (5)
- A calibrated functional patch clamp assay to enhance clinical variant interpretation in KCNH2-related long QT syndrome (2021) (5)
- Revisiting the Diagnostic Yield of Hypertrophic Cardiomyopathy Genetic Testing (2020) (5)
- Causes, circumstances, and potential preventability of cardiac arrest in the young: insights from a state-wide clinical and forensic registry. (2022) (4)
- Reply: What Is the True Prevalence of Hypertrophic Cardiomyopathy? (2015) (4)
- Clinical Profile and Health Disparities in a Multiethnic Cohort of Patients With Hypertrophic Cardiomyopathy (2021) (4)
- A Needs Analysis of Parents Following Sudden Cardiac Death in the Young (2019) (4)
- Making The Case For Cascade Screening Amongst Families With Inherited Heart Diseases. (2019) (4)
- Predictors and outcomes of in-hospital referrals for forensic investigation after young sudden cardiac death. (2022) (3)
- Decision-making and experiences of preimplantation genetic diagnosis in inherited heart diseases: a qualitative study (2021) (3)
- Daily Step Count as a Simple Marker of Disease Severity in Hypertrophic Cardiomyopathy. (2018) (3)
- Genetics of HCM and Role of Genetic Testing (2018) (3)
- How Patient Perceptions Shape Responses and Outcomes in Inherited Cardiac Conditions. (2019) (3)
- A cost-effectiveness analysis of genetic testing in the evaluation of families with hypertrophic cardiomyopathy (2011) (3)
- Adaptation and validation of the ACMG / AMP variant classification framework for MYH 7-associated inherited cardiomyopathies (2018) (3)
- The social gradient of taking a family history (2015) (3)
- Sudden death in athletes: preventable or inevitable? (2014) (2)
- Erratum to “Guidelines for Genetic Testing of Inherited Cardiac Disorders” [Heart Lung Circ. 20 (2011) 681–687] (2012) (2)
- Concealed Cardiomyopathy in Autopsy-Inconclusive Cases of Sudden Cardiac Death and Implications for Families. (2022) (2)
- Mutation analysis of the natriuretic peptide precursor B (NPPB) gene in patients with hypertrophic cardiomyopathy (2006) (2)
- Letter by Semsarian and Ingles regarding article, "A randomized trial of social media from Circulation". (2015) (2)
- A prospective longitudinal study of health-related quality of life and psychological wellbeing after an implantable cardioverter-defibrillator in patients with genetic heart diseases (2021) (2)
- Prevalence of Coronary Artery Anomalies in Young and Middle-Aged Sudden Cardiac Death Victims (from a Prospective State-Wide Registry). (2022) (2)
- Family Matters: Outcomes of Hypertrophic Cardiomyopathy Family Screening. (2018) (2)
- Evaluating a custom-designed aid to improve communication of genetic results in families with hypertrophic cardiomyopathy: study protocol for a randomised controlled trial (2019) (2)
- Prevalence of Anderson-Fabry disease in a cohort with unexplained late gadolinium enhancement on cardiac MRI. (2019) (2)
- Harmonizing the Collection of Clinical Data on Genetic Testing Requisition Forms to Enhance Variant Interpretation in Hypertrophic Cardiomyopathy (HCM) (2021) (2)
- Abstract 20544: Family History Characteristics as Risk Factors for Sudden Cardiac Death Events in Hypertrophic Cardiomyopathy (2014) (1)
- Genetic Basis of Childhood Cardiomyopathy (2022) (1)
- Evaluating a communication aid for return of genetic results in families with hypertrophic cardiomyopathy: A randomized controlled trial (2021) (1)
- What do we do and how do we do it? Assessing genetic counselling in the modern era (2020) (1)
- Inconsistent discharge diagnoses for young cardiac arrest episodes: insights from a state-wide registry. (2022) (1)
- Synopsis of an integrated guidance for enhancing the care of familial hypercholesterolaemia: an Australian perspective (2021) (1)
- Efficacy of flecainide in a large cohort of patients with catecholaminergic polymorphic ventricular tachycardia (2016) (1)
- Abstract 19096: Evaluating Hypertrophic Cardiomyopathy Disease-Gene Associations Using the Clinical Genome Resource (ClinGen) Gene Curation Framework (2017) (1)
- Participation in thrill-seeking activities by patients with hypertrophic cardiomyopathy: Individual preferences, adverse events and physician attitude. (2019) (1)
- Abstract 11709: The Impact of Hypertension on Disease Expression in Hypertrophic Cardiomyopathy (2021) (1)
- An Unexpected FLNC Phenotype: Expanding the Clinical Spectrum or a Second-Hit Disease Mechanism? (2019) (1)
- Indications and utility of cardiac genetic testing in athletes. (2022) (1)
- What Is the Risk of Sudden Cardiac Arrest in Inherited Cardiac Conditions? (2020) (1)
- The role of genetic testing in diagnosis and care of inherited cardiac conditions in a specialised multidisciplinary clinic (2022) (1)
- Routinely collected health data to study inherited heart disease: a systematic review (2000–2016) (2017) (1)
- Penetrance of Dilated Cardiomyopathy in Families with Truncating TTN Variants: a National Perspective (2019) (1)
- Using codesign focus groups to develop an online COmmunity suPporting familiEs after Sudden Cardiac Death (COPE-SCD) in the young (2022) (1)
- Investigation of current models of care for genetic heart disease in Australia: A national clinical audit. (2021) (1)
- Whole genome sequencing delineates regulatory, copy number, and cryptic splice variants in early onset cardiomyopathy (2022) (1)
- Cost-Effectiveness of the ‘Molecular Autopsy’ in Sudden Unexplained Death in the Young (2012) (1)
- Response to Brodehl et al. (2018) (0)
- Clinical and Pathologic Features of Out-of-Hospital Cardiac Arrest in Pregnancy: Insights From a State-Wide Registry (2022) (0)
- “Concealed Cardiomyopathy” is an Important Cause of Autopsy-Inconclusive Sudden Cardiac Death and Diagnosis Impacts Care of Surviving Relatives (2022) (0)
- A Novel Heterozygous Mutation in Cardiac Calsequestrin Causes Catecholaminergic Polymorphic Ventricular Tachycardia (2016) (0)
- Abstract 16484: Primary Prevention Implantable Cardioverter Defibrillator Utilization for Hypertrophic Cardiomyopathy in US vs Non-US: Findings From the Share Registry (2020) (0)
- Concealed Cardiomyopathy as a Cause of Sudden Cardiac Death (2021) (0)
- Sudden cardiac death from genetic heart disease: psychological impact to the surviving at-risk family members (2015) (0)
- Sudden cardiac death from genetic heart disease: psychological impact to the surviving at-risk family members (2015) (0)
- Sudden cardiac death from genetic heart disease: psychological impact to the surviving at-risk family members (2015) (0)
- NSW HEARTS: The NSW Inherited Cardiomyopathy Cohort Study protocol (2022) (0)
- Frequency of RASopathy Gene Variants in Patients with Inherited Cardiomyopathies (2019) (0)
- Clinical Genetics (2020) (0)
- Care of the patient with inherited cardiac conditions and congenital heart diseases (2021) (0)
- 030 Improving the Yield of Genetic Testing in Sudden Cardiac Arrest Survivors: Clinical Predictors and Extended Genetic Assessment (2020) (0)
- Beyond gene-disease validity: capturing structured data on inheritance, allelic-requirement, disease-relevant variant classes, and disease mechanism for inherited cardiac conditions (2023) (0)
- Truncating Variants in the Desmoplakin Gene Cause a Distinct Arrhythmogenic Cardiomyopathy (2019) (0)
- Contribution and Functional Characterisation of Splice-Disrupting Variants in Inherited Heart Disease and Sudden Cardiac Death (2022) (0)
- The Need for Inclusive Genomic Research (2022) (0)
- Prevalence, Clinical Course and Development of Atrial Fibrillation in Sarcomere-Positive Hypertrophic Cardiomyopathy (2019) (0)
- Prevalence of Mitochondrial Genome Variants in an Inherited Heart Disease Cohort (2022) (0)
- Genetic variants associated with inherited cardiovascular disorders among 13,131 asymptomatic older adults of European descent (2021) (0)
- 592 Using Phenotype and Genomics to Solve Undiagnosed Cardiac Diseases: A Family With Unsolved Conduction Disease and Sudden Cardiac Death (2020) (0)
- Characterization of clinically relevant copy-number variants from exomes of patients with inherited heart disease and unexplained sudden cardiac death (2020) (0)
- Using co-design to develop an online intervention for families after a sudden cardiac death in the young (2021) (0)
- The Australian National Genetic Heart Disease Registry (2011) (0)
- 591 The Australian Genetic Heart Disease Registry: 13 Years on (2020) (0)
- The genetic heart disease patient day: Improving education and patient understanding (2015) (0)
- The Elusive Hearts Study: Seeking Genetic Diagnoses in Gene-elusive Cases of Rare Monogenic Cardiovascular Diseases (2022) (0)
- Abstract 16784: Participation in Thrill-Seeking Activities for Hypertrophic Cardiomyopathy Patients (2018) (0)
- Evaluation of Psychological Wellbeing in Patients with Hypertrophic Cardiomyopathy (2007) (0)
- Disease-specific variant pathogenicity prediction significantly improves variant interpretation in inherited cardiac conditions (2020) (0)
- Presence of an RYR2 Mutation is Associated with Sudden Cardiac Events at Presentation in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) (2013) (0)
- Evaluation of illumina trusight cardiomyopathy panel testing for detection of diagnostically relevant abnormalities in hypertrophic cardiomyopathy (2017) (0)
- Illumina TruSight Cardiomyopathy Sequencing Panel: Application to hypertrophic cardiomyopathy (2014) (0)
- Effects of Mood and Metabolic Disorders on Mitochondrial Function, Infarct Tolerance, and Cardioprotection (2022) (0)
- Effects of Energy Drinks in Familial Long QT Syndrome : A Randomized Cross-Over Study (2017) (0)
- P Hypertrophic Cardiomyopathy Mutations in Alpha-Actinin-2 Cause Hypertrophic Cardiomyopathy (0)
- Prevalence of Atrial Fibrillation in Patients with Inherited Heart Disease (2019) (0)
- Engaging the Cardiovascular Community using Twitter (2012) (0)
- Prevalence of Fabry Disease in A Cohort with Unexplained Late Gadolinium Enhancement on Cardiac MRI (2019) (0)
- Abstract 14117: Clinical Characteristics and Cardiovascular Outcomes in Childhood-Onset Hypertrophic Cardiomyopathy (2020) (0)
- Whole genome sequencing delineates regulatory, copy number, and cryptic splice variants in early onset cardiomyopathy (2022) (0)
- Prevalence of Illicit Drug Use in Young Sudden Cardiac Death Patients – an Australian Prospective Cohort Study (2022) (0)
- Abstract 11792: Low Penetrance Sarcomere Variants Indicate an Additive Genetic Risk Model in Hypertrophic Cardiomyopathy (2021) (0)
- Sudden Cardiac Death in People With Schizophrenia (2023) (0)
- Hypertrophic Cardiomyopathy With Left Ventricular Systolic Dysfunction Insights the Registry (2020) (0)
- The National Genetic Heart Disease Registry: Progress to date (2009) (0)
- The Australian Genetic Heart Disease Registry: The First Five Years (2013) (0)
- Genetic counselling (2018) (0)
- Abstract 10610: Severity of Hypertrophy and Increased QTc Interval Predict Appropriate ICD Therapies in Hypertrophic Cardiomyopathy (2012) (0)
- Exome sequencing identifies a novel mutation in the MYH6 gene in a family with early onset sinus node dysfunction, ventricular arrhythmias, and cardiac arrest (2015) (0)
- COPESCD — An Online Community Supporting Families After Sudden Cardiac Death in the Young: A Protocol for a Pilot Study (2022) (0)
- Perceptions of genetic variant reclassification in patients with inherited cardiac disease (2019) (0)
- The National Genetic Heart Disease Registry: An update (2010) (0)
- The key role of family history in predicting genetic testing outcomes in hypertrophic cardiomyopathy (2012) (0)
- Exome sequencing identifies a novel mutation in the MYH6 gene in a family with early onset sinus node dysfunction, ventricular arrhythmias, and cardiac arrest (2015) (0)
- Decision-making and experiences of preimplantation genetic diagnosis in inherited heart diseases: a qualitative study (2021) (0)
- Atrial Fibrillation is Associated with Increased Mortality and Implantable Cardioverter Defibrillator Events in Hypertrophic Cardiomyopathy: A 10 Year Follow-Up (2012) (0)
- Determining Pathogenicity of Genetic Variants in Hypertrophic Cardiomyopathy: Experience from a Multidisciplinary Clinic (2013) (0)
- Sudden cardiac death in the young: A qualitative study of experiences of family members with cardiogenetic evaluation (2022) (0)
- Familial Factors Predispose to Increased Risk of Ventricular Arrhythmias in Patients with Hypertrophic Cardiomyopathy (2019) (0)
- Co-designing an online COmmunity suPporting familiEs after Sudden Cardiac Death (COPE-SCD) in the young (2021) (0)
- New York Heart Association Functional Class And Mortality In Obstructive Hypertrophic Cardiomyopathy (2022) (0)
- Genome-wide Linkage Analysis Identifies α-Actinin-2 as a Causative Gene in Familial Hypertrophic Cardiomyopathy (2009) (0)
- Response by Ingles and Semsarian to Letter Regarding Article, "Concealed Arrhythmogenic Right Ventricular Cardiomyopathy in Sudden Unexplained Cardiac Death Events". (2019) (0)
- Abstract 15391: The Natural History of Asymptomatic and Mildly Symptomatic Obstructive Hypertrophic Cardiomyopathy: Insights From the Share Registry (2020) (0)
- Access, uptake and communication of genetic test results in Australian families with long QT syndrome (LQTS) (2014) (0)
- Global approaches to postmortem genetic testing after sudden cardiac death in the young: A survey among healthcare professionals (2020) (0)
- Higher rates but similar causes of young out-of-hospital cardiac arrest in rural Australian patients. (2022) (0)
- Correction to: The genetic architecture of Plakophilin 2 cardiomyopathy (2021) (0)
- Abstract 11857: Benchmarking a Functional Assay to Assist Clinical Classification of Variants of Uncertain Significance in KCNH2 (Long QT Syndrome Type 2) (2021) (0)
- Correction: Determining pathogenicity of genetic variants in hypertrophic cardiomyopathy: importance of periodic reassessment (2018) (0)
- Sudden Cardiac Arrest in the Pediatric Population (2022) (0)
- Inherited cardiomyopathies (2021) (0)
- Psychological adaptation to molecular autopsy findings following sudden cardiac death in the young (2018) (0)
- Worldwide differences in primary prevention implantable cardioverter defibrillator utilization and outcomes in hypertrophic cardiomyopathy. (2021) (0)
- Clinical and genetic characteristics of hypertrophic cardiomyopathy patients with end-stage disease: A registry-based study (2014) (0)
- O082 Evidence for declining trends in sudden cardiac death in men and women from 1995 to 2010 (2014) (0)
- Genome-Wide Analysis Mutations in Alpha-Actinin-2 Cause Hypertrophic Cardiomyopathy: A (2011) (0)
- Sex Disaggregated Analysis of Risk Factors for Adverse Outcomes in Hypertrophic Cardiomyopathy (2022) (0)
- 579 Absence of Pathogenic Variants in Patients With Isolated Left Ventricular Trabeculations After Deep Phenotyping (2020) (0)
- Confounder bias in sudden death risk stratification for hypertrophic cardiomyopathy (2015) (0)
- The formation of a cardiac arrest registry in Australia [End unexplained cardiac death (EndUCP) registry] (2021) (0)
- The Australian National Genetic Heart Disease Registry: An Update (2011) (0)
- Genetic Heart Diseases in Tasmania (2011) (0)
- In This Issue (2013) (0)
- Correction: Determining pathogenicity of genetic variants in hypertrophic cardiomyopathy: importance of periodic reassessment (2018) (0)
- Obesity in young sudden cardiac death: Rates, clinical features, and insights into people with body mass index >50kg/m2 (2022) (0)
- The Dynamic and Multifaceted Nature of Cardiovascular Disease and Using Genetic Testing to Inform Clinical Care: An International Perspective. (2020) (0)
- “Concealed cardiomyopathy” as a cause of previously unexplained sudden cardiac arrest (2020) (0)
- Assessment of Physical Activity in Hypertrophic Cardiomyopathy (2016) (0)
- End Unexplained Cardiac Death (EndUCD) NSW Registry: A Data Linkage Cohort Study Protocol (2022) (0)
- Prevalence of Coronary Artery Anomalies in Young Sudden Cardiac Death: Insights From a Prospective State-Wide Registry (2022) (0)
- Social Media and Cardiac Rehabilitation: A Systematic Review (2012) (0)
- Abstract 14781: Computational Prediction of Protein Subdomain Stability as a Novel Approach to Cardiac Myosin Binding ProteinC Variant Adjudication and Clinical Risk Stratification in Hypertrophic Cardiomyopathy (2020) (0)
- 588 Seek and You Shall Find: A Case Highlighting the Importance of Multisystem Assessment in Arrhythmogenic Cardiomyopathy (2020) (0)
- Doctor-patient care relationship in genetic cardiomyopathies: An exploratory study on clinical consultations (2020) (0)
- 71 – Genetic Testing (2014) (0)
- The National Genetic Heart Disease Registry (2008) (0)
- 015 Clinical Profile and Management of Hypertrophic Cardiomyopathy in a Multi-Ethnic Australian Cohort (2020) (0)
- Clinical and Genetic Challenges In Adult-Onset Left Ventricular Non–Compaction (2018) (0)
- Editorial commentary: Genetic contributions to cardiovascular disease: The blurred lines between monogenic and polygenic traits. (2017) (0)
- Multiple Gene Variants in Hypertrophic Cardiomyopathy in the Era of Next Generation Sequencing (2017) (0)
- Genetic testing for inherited heart diseases: The National Genetic Heart Disease Registry (2008) (0)
- 1216Non-invasive multimodality assessment in brugada Syndrome: insights into pathogenic basis and risk stratification (2017) (0)
- Response to Brodehl et al. (2018) (0)
- A Novel Heterozygous Mutation in Cardiac Calsequestrin Causes Catecholaminergic Polymorphic Ventricular Tachycardia (2016) (0)
- A Novel Heterozygous Mutation in Cardiac Calsequestrin Causes Catecholaminergic Polymorphic Ventricular Tachycardia (2016) (0)
This paper list is powered by the following services:
Other Resources About Jodie Ingles
What Schools Are Affiliated With Jodie Ingles?
Jodie Ingles is affiliated with the following schools:
